Sree Roy

Key takeaways: EnsoData’s EnsoSleep is the first to receive full autoscoring certification from the AASM. The certification validates performance across sleep staging, respiratory events, arousals, and periodic limb movements. The independent evaluation assesses performance against a dataset of more than 140 real-world polysomnography studies.

Aug 25, 2026 In January, Jeff La Marca got a prescription for the popular weight loss drug Zepbound. But he couldn’t afford the $750 monthly price tag. Then Medicare launched an 18-month pilot program that offers GLP-1 medications to some enrollees for only $50 a month. La Marca thought he might finally be able to afford the drug. “I thought, ‘Thank God, there’s a path,’” said La Marca, who lives in Basking Ridge, New Jersey, and has tried numerous diets and exercise regimes.

I recently spoke with Liz Burgess, the new executive director of Narcolepsy Network, who took the helm during the organization’s 40th anniversary. Her appointment comes at a pivotal time, with the first orexin agonists marking what she calls a “historic shift in the sleep disorder space” for treating the root cause of narcolepsy type 1. But our conversation quickly moved beyond pharmacology to the human side of care—the part that happens after a patient leaves the clinic with a new prescription.